Publications by authors named "Stefan Lind"

Aims: Left bundle branch block (LBBB) might be the first finding of cardiovascular diseases but also the prerequisite for cardiac resynchronization therapy (CRT) in heart failure (HF) with reduced ejection fraction (HFrEF). The prognosis for patients with LBBB and the implications of CRT in an unselected real-world setting are the focus of our study.

Methods And Results: A central electrocardiogram (ECG) database and national registers have been screened to identify patients with LBBB.

View Article and Find Full Text PDF

Objectives: There is a lack of robust epidemiological evidence on antipsychotic (AP) use in patients with agitation in Alzheimer's disease (AD). Authors studied AP use in patients with AD and agitation and compared their use with patients with other or no neuropsychiatric symptoms (NPS).

Methods: A retrospective cohort study in the UK Clinical Practice Research Datalink, included patients with AD between January 1, 2015, and December 31, 2017.

View Article and Find Full Text PDF

Aims: Our main objectives were to evaluate the effect of surgery using self-assessed health scores. Secondary objectives were to correlate outcome with grade of deformity (Stulberg classification I-V) or age at surgery and whether additional periacetabular osteotomy (PAO) is beneficial for patients with concurrent acetabular dysplasia.

Methods: This was a retrospective cohort and in part a cross sectional study using a planned clinical and radiological follow-up of patients.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate whether using dabigatran, a direct oral anticoagulant (DOAC), before elective direct current cardioversion for non-acute atrial fibrillation reduces the risk of thromboembolism compared to warfarin.
  • Researchers analyzed medical records of 631 patients who used dabigatran prior to cardioversion, focusing on the occurrence of thromboembolism within 30 days of the procedure.
  • Results showed a low incidence of thromboembolism (0.53%) in patients pre-treated with dabigatran, suggesting it is a safe alternative to warfarin for this medical procedure.
View Article and Find Full Text PDF